Price $32.27 |
Market Cap
2.67B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
136.6
|
P/B
4.31
|
P/S
4.74
|
Dividend %
-
|
|
P/CF
74.3
|
P/FCF
46.0
|
Op. Cash Flow
89.4K
|
FCF
0.7
|
|
Op. Margin
7.70%
|
Net Margin
6.20%
|
ROE
5.80%
|
ROI
4.20%
|
|
ROA
3.60%
|
EPS Growth
6.30%
|
Current Ratio
3.2
|
Debt/Equity
39.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $16.29 | - | - | 3.74B | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.91 | - | - | 72.7M | Strong Buy |
| Vaxart Inc (VXRT) | $3.03 | - | - | 21.9M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $4.30 | - | - | 32M | Strong Buy |
| Procyon Corp (PCYN) | $0.28 | - | - | 2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
